Coram, CVS Specialty Infusion Services, in Albany, N.Y. is set to close its doors at 12 Jupiter Lane.
In a notice on June 1, the New York State Department of Labor’s Office of dislocated workers program stated that the business will be permanently closing its Albany facility, affecting a total of 70 employees.
Separations will occur during the 14-day period starting on Sept. 4, 2022. The closing date is Sept. 18, 2022, according to the NYS Department of Labor.
The department cited "economic" as the reason for the closure of the clinic.
Commenting on the closure, a CVS spokesperson provided the following statement, "As the leading health solutions company, we use our unique combination of assets to lower costs, increase access to care and improve health outcomes. We regularly review operations to focus resources as efficiently as possible and pivot when necessary to invest in healthcare services and solutions that will make the greatest impact. After a recent review, we’ve decided to focus more resources on patients who receive infusion services for specialty medications and limit the delivery of acute infusion services (such as infused antibiotics and total parenteral nutrition)."
The statement continued, "As a result, we are closing the Coram pharmacy location in Albany, New York. Patient safety and continuity of care remain of utmost importance to us. We have a comprehensive transition plan in place for any patient affected by these changes. A dedicated team will work directly with impacted patients to help them find a new provider and seamlessly transition their care."
"We will also work to help any impacted colleagues find other suitable roles within Coram or CVS Health and will provide career transition support for those who are not able to do so," CVS Health said.
The statement concluded, "The market for infusion services for specialty medications continues to see sustained growth. Coram has been a leading provider of infusion services for specialty medication for over 30 years and is uniquely positioned to continue to meet the needs of this growing market and service our patients in a more targeted, resourced way."